How to cite this paper
Rajendraprasad, N & Basavaiah, K. (2016). Potentiometric determination of piroxicam and oxfendazole in pharmaceuticals.Current Chemistry Letters, 5(1), 33-46.
Refrences
1. Mammen, L., Schmidt, C.P. (1995). Photosensitivity reactions: a case report involving NSAIDs. American Family Physician, 52 (2) 575–579.
2. http://www.chemicalland21.com/lifescience/phar/OXFENDAZOLE.htm.
3. Vire, J-C., Kauffman, J-M., Braun, J., Patriarche, G. J. (1985). Analytical study of piroxicam. Journal De Pharmacie De Belgique, 40 (3) 133-138.
4. Donato, M. G., Baeyens, W., Van Den Bossche, W., Sandra, P. (1994). The determination of non-steroidal anti-inflammatory drugs in pharmaceuticals by capillary zone electrophoresis and micellar electrokinetic capillary chromatography. Journal of Pharmaceutical and Biomedical Analysis, 12 (1) 21–26.
5. Dadashzadeh, S., Vali, A. M., Rezagholi N. J. (2002). LC determination of piroxicam in human plasma. Journal of Pharmaceutical and Biomedical Analysis, 28 (6) 1201- 1204.
6. Doliwa, A., Santoyo, S., Campanero, M. A., Ygartua, P. (2001). Sensitive LC determination of piroxicam after in vitro transdermal permeation studies. Journal of Pharmaceutical and Biomedical Analysis, 26 (4) 531- 537.
7. Ji, H.Y., Lee, H. W., Kim, Y. H., Jeong, D. W., Lee, H. S. (2005). Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry. Journal of Chromatography B, 826 (1-2) 214- 219.
8. Amanlou, M., Dehpour, A. R. (1997). Rapid method for the determination of piroxicam in rat plasma using high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 696 (2) 317-319.
9. Basan, H, G??er, N. G., Erta?, N., Orbey M. T. (2001). Quantitative determination of piroxicam in a new formulation (piroxicam-beta-cyclodextrin) by derivative UV spectrophotometric method and HPLC. Journal of Pharmaceutical and Biomedical Analysis, 26 (2) 171-178.
10. Starek, M., Krzek, J., Tarsa, M., ?ylewski, M. (2009). Determination of piroxicam and degradation products in drugs by TLC. Chromatographia, 69 (3-4) 351-356.
11. Sava?er, A., Karata?, A., ?zkan, Y., Yüksel, N., ?zkan, S. A., Baykara, T. (2004). Validated LC determination of the piroxicam-B-cyclodextrin inclusion complex in tablets and in human plasma. Chromatographia, 59 (9-10) 555-560.
12. Escandar, G. M., Bystol, A. J., Campiglia, A. D. (2002). Spectrofluorimetric method for the determination of piroxicam and pyridoxine. Analytica Chimica Acta, 466 (2) 275–283.
13. Damiani, P. C., Bearzotti, M., Cabez?n, M., Olivieri, A. C. (1998). Spectrofluorometric determination of piroxicam. Journal of Pharmaceutical and Biomedical Analysis, 17 (2) 233-236.
14. Amin, A. S., El-Didamony, A. M. (2004). Adaptation of a color reaction for spectrophotometric determination of diclofenac sodium and piroxicam in pure form and in pharmaceutical formulations. Analytical Letters, 37 (6) 1151-1162.
15. Gowda, B. G., Seetharamappa, J., Melwanki, M. B. (2002). Indirect spectrophotometric determination of propanalol hydrochloride and piroxicam in pure and pharmaceutical formulations. Analytical Sciences, 18 (6) 671- 674.
16. Al-Momani, I. F. (2006). Indirect flow-injection spectrophotometric determination of meloxicam, tenoxicam and piroxicam in pharmaceutical formulations. Analytical Sciences, 22 (12) 1611- 1614.
17. El-Ries, M. A. (1998). Spectrophotometric determination of piroxicam and tenoxicam in pharmaceutical preparations using uranyl acetate as a chromogenic agent. Analytical Letters, 31 (5) 793-807.
18. Sastry, C. S. P., Rama Srinivas, K., Krishna Prasad, K. M. M. (1996). Sevron blue 5G as an ion-pairing reagent for the determination of acidic drugs in pharmaceutical formulations. Indian Journal of Pharmaceutical Sciences, 58 (3) 120-122.
19. Rao, B. E., Raghuveer, S., Srivastav, C. M. R., Vatsa, D. K. (1993). Spectrophotometric determination of piroxicam in capsules and tablets. Indian Drugs, 30 (4) 194-197.
20. Wang, G. (1989). Ultra-violet spectrophotometric determination of piroxicam in tablets. Yaowu Fenxi Zazhi, 9 (3) 189-190.
21. Tsina, I. W., Matin, S. B. (1981). Determination of oxfendazole in cow milk by reversed-phase high-performance liquid chromatography. Journal of Pharmaceutical Sciences, 70 (8) 858-60.
22. Shah, G., Bradley, D., Shek, E. (1984). Liquid chromatographic determination of oxfendazole in swine feeds. Journal of the Association of Official Analytical Chemists, 67 (4) 707-714.
23. Blanchflower, W. J., Cannavan, A., Kennedy, D. G. (1994). Determination of fenbendazole and oxfendazole in liver and muscle using liquid chromatography-mass spectrometry. Analyst, 119 (6)1325-1328.
24. Su, S-C., Chou, H-H., Chang, P-C., Liu, C-H., Chou, S-S. (2004). Oxfendazole and oxfendazole sulfone in livestock by matrix solid phase dispersion extraction technique and HPLC. Journal of Food and Drug Analysis, 12 (3) 244-253.
25. Dimitrios, S. N., Nickos, A. B., Ioannis, E. P. (1994). Ion-Pair isolation and liquid chromatographic determination of albendazole, oxfendazole, oxibendazole, and thiabendazole residues in milk. Journal of Liquid Chromatography, 17 (19) 4145-4155
26. Lucie, H., Ivana, B., Dalibor, ?., Ludmila, M., Alena, L., Zden?k, O., Petr, S. (2012). Optimisation of an HPLC method for the simultaneous determination of pyrantel pamoate, praziquantel, fenbendazole, oxfendazole and butylhydroxyanisole using a phenyl stationary phase. Analytical Methods, 4 (6) 1592-1597
27. LeVan, L. W., Barnes C. J. (1991). Liquid chromatographic method for multiresidue determination of benzimidazoles in beef liver and muscle: collaborative study. Journal of the Association of Official Analytical Chemists, 74 (3) 487-493.
28. Nerenberg, C., Runkel, R. A., Matin, S. B. (1978). Radioimmunoassay of oxfendazole in bovine, equine, or canine plasma or serum. Pharmaceutical Sciences, 67 (11) 1553-1557.
29. Dinc, E., Onur, F. (1997). Comparative study of the ratio spectra derivative spectrophotometry, derivative spectrophotometry and Vierordt’s method applied to the analysis of oxfendazole and oxyclozanide in a veterinary formulation. Analusis, 25 (3) 55-59.
30. Dinç, E., Kanbur, M. (2002). Spectrophotometric multicomponent resolution of a veterinary formulation containing oxfendazole and oxyclozanide by multivariate calibration–prediction techniques. Journal of Pharmaceutical and Biomedical Analysis, 28 (3-4) 779-788.
31. Dinç, E., B?leanu D. (2007) Continuous wavelet transform applied to the overlapping absorption signals and their ratio signals for the quantitative resolution of mixture of oxfendazole and oxyclozanide in bolus. Journal of Food and Drug Analysis, 15 (2) 109-117.
32. European Pharmacopoeia (1997), 3rd Edition, Council of Europe, France, p. 55.
33. United States Pharmacopoiea (2008) 32–NF27, pp. 3155.
34. International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R 1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.
35. Jiri Kucharski, R. N., Safarik, L. (1965). Titrations In Non-Aqueous Solvents”. 1th Ed, Elsevier Publishing Company, Amsterdam-London-New York, p. 94.
36. Miller, J. N., Miller J.C. (2000). Statistics and Chemometrics for Analytical Chemistry, 4th Ed, Pearson Education Limited, England.
2. http://www.chemicalland21.com/lifescience/phar/OXFENDAZOLE.htm.
3. Vire, J-C., Kauffman, J-M., Braun, J., Patriarche, G. J. (1985). Analytical study of piroxicam. Journal De Pharmacie De Belgique, 40 (3) 133-138.
4. Donato, M. G., Baeyens, W., Van Den Bossche, W., Sandra, P. (1994). The determination of non-steroidal anti-inflammatory drugs in pharmaceuticals by capillary zone electrophoresis and micellar electrokinetic capillary chromatography. Journal of Pharmaceutical and Biomedical Analysis, 12 (1) 21–26.
5. Dadashzadeh, S., Vali, A. M., Rezagholi N. J. (2002). LC determination of piroxicam in human plasma. Journal of Pharmaceutical and Biomedical Analysis, 28 (6) 1201- 1204.
6. Doliwa, A., Santoyo, S., Campanero, M. A., Ygartua, P. (2001). Sensitive LC determination of piroxicam after in vitro transdermal permeation studies. Journal of Pharmaceutical and Biomedical Analysis, 26 (4) 531- 537.
7. Ji, H.Y., Lee, H. W., Kim, Y. H., Jeong, D. W., Lee, H. S. (2005). Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry. Journal of Chromatography B, 826 (1-2) 214- 219.
8. Amanlou, M., Dehpour, A. R. (1997). Rapid method for the determination of piroxicam in rat plasma using high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 696 (2) 317-319.
9. Basan, H, G??er, N. G., Erta?, N., Orbey M. T. (2001). Quantitative determination of piroxicam in a new formulation (piroxicam-beta-cyclodextrin) by derivative UV spectrophotometric method and HPLC. Journal of Pharmaceutical and Biomedical Analysis, 26 (2) 171-178.
10. Starek, M., Krzek, J., Tarsa, M., ?ylewski, M. (2009). Determination of piroxicam and degradation products in drugs by TLC. Chromatographia, 69 (3-4) 351-356.
11. Sava?er, A., Karata?, A., ?zkan, Y., Yüksel, N., ?zkan, S. A., Baykara, T. (2004). Validated LC determination of the piroxicam-B-cyclodextrin inclusion complex in tablets and in human plasma. Chromatographia, 59 (9-10) 555-560.
12. Escandar, G. M., Bystol, A. J., Campiglia, A. D. (2002). Spectrofluorimetric method for the determination of piroxicam and pyridoxine. Analytica Chimica Acta, 466 (2) 275–283.
13. Damiani, P. C., Bearzotti, M., Cabez?n, M., Olivieri, A. C. (1998). Spectrofluorometric determination of piroxicam. Journal of Pharmaceutical and Biomedical Analysis, 17 (2) 233-236.
14. Amin, A. S., El-Didamony, A. M. (2004). Adaptation of a color reaction for spectrophotometric determination of diclofenac sodium and piroxicam in pure form and in pharmaceutical formulations. Analytical Letters, 37 (6) 1151-1162.
15. Gowda, B. G., Seetharamappa, J., Melwanki, M. B. (2002). Indirect spectrophotometric determination of propanalol hydrochloride and piroxicam in pure and pharmaceutical formulations. Analytical Sciences, 18 (6) 671- 674.
16. Al-Momani, I. F. (2006). Indirect flow-injection spectrophotometric determination of meloxicam, tenoxicam and piroxicam in pharmaceutical formulations. Analytical Sciences, 22 (12) 1611- 1614.
17. El-Ries, M. A. (1998). Spectrophotometric determination of piroxicam and tenoxicam in pharmaceutical preparations using uranyl acetate as a chromogenic agent. Analytical Letters, 31 (5) 793-807.
18. Sastry, C. S. P., Rama Srinivas, K., Krishna Prasad, K. M. M. (1996). Sevron blue 5G as an ion-pairing reagent for the determination of acidic drugs in pharmaceutical formulations. Indian Journal of Pharmaceutical Sciences, 58 (3) 120-122.
19. Rao, B. E., Raghuveer, S., Srivastav, C. M. R., Vatsa, D. K. (1993). Spectrophotometric determination of piroxicam in capsules and tablets. Indian Drugs, 30 (4) 194-197.
20. Wang, G. (1989). Ultra-violet spectrophotometric determination of piroxicam in tablets. Yaowu Fenxi Zazhi, 9 (3) 189-190.
21. Tsina, I. W., Matin, S. B. (1981). Determination of oxfendazole in cow milk by reversed-phase high-performance liquid chromatography. Journal of Pharmaceutical Sciences, 70 (8) 858-60.
22. Shah, G., Bradley, D., Shek, E. (1984). Liquid chromatographic determination of oxfendazole in swine feeds. Journal of the Association of Official Analytical Chemists, 67 (4) 707-714.
23. Blanchflower, W. J., Cannavan, A., Kennedy, D. G. (1994). Determination of fenbendazole and oxfendazole in liver and muscle using liquid chromatography-mass spectrometry. Analyst, 119 (6)1325-1328.
24. Su, S-C., Chou, H-H., Chang, P-C., Liu, C-H., Chou, S-S. (2004). Oxfendazole and oxfendazole sulfone in livestock by matrix solid phase dispersion extraction technique and HPLC. Journal of Food and Drug Analysis, 12 (3) 244-253.
25. Dimitrios, S. N., Nickos, A. B., Ioannis, E. P. (1994). Ion-Pair isolation and liquid chromatographic determination of albendazole, oxfendazole, oxibendazole, and thiabendazole residues in milk. Journal of Liquid Chromatography, 17 (19) 4145-4155
26. Lucie, H., Ivana, B., Dalibor, ?., Ludmila, M., Alena, L., Zden?k, O., Petr, S. (2012). Optimisation of an HPLC method for the simultaneous determination of pyrantel pamoate, praziquantel, fenbendazole, oxfendazole and butylhydroxyanisole using a phenyl stationary phase. Analytical Methods, 4 (6) 1592-1597
27. LeVan, L. W., Barnes C. J. (1991). Liquid chromatographic method for multiresidue determination of benzimidazoles in beef liver and muscle: collaborative study. Journal of the Association of Official Analytical Chemists, 74 (3) 487-493.
28. Nerenberg, C., Runkel, R. A., Matin, S. B. (1978). Radioimmunoassay of oxfendazole in bovine, equine, or canine plasma or serum. Pharmaceutical Sciences, 67 (11) 1553-1557.
29. Dinc, E., Onur, F. (1997). Comparative study of the ratio spectra derivative spectrophotometry, derivative spectrophotometry and Vierordt’s method applied to the analysis of oxfendazole and oxyclozanide in a veterinary formulation. Analusis, 25 (3) 55-59.
30. Dinç, E., Kanbur, M. (2002). Spectrophotometric multicomponent resolution of a veterinary formulation containing oxfendazole and oxyclozanide by multivariate calibration–prediction techniques. Journal of Pharmaceutical and Biomedical Analysis, 28 (3-4) 779-788.
31. Dinç, E., B?leanu D. (2007) Continuous wavelet transform applied to the overlapping absorption signals and their ratio signals for the quantitative resolution of mixture of oxfendazole and oxyclozanide in bolus. Journal of Food and Drug Analysis, 15 (2) 109-117.
32. European Pharmacopoeia (1997), 3rd Edition, Council of Europe, France, p. 55.
33. United States Pharmacopoiea (2008) 32–NF27, pp. 3155.
34. International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R 1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.
35. Jiri Kucharski, R. N., Safarik, L. (1965). Titrations In Non-Aqueous Solvents”. 1th Ed, Elsevier Publishing Company, Amsterdam-London-New York, p. 94.
36. Miller, J. N., Miller J.C. (2000). Statistics and Chemometrics for Analytical Chemistry, 4th Ed, Pearson Education Limited, England.